Skip to main content

DA Butterfield

First name:
DA
Last name:
Butterfield
Castegna, A. ., , Klein, J. ., Lynn, B. ., Markesbery, W. ., & Butterfield, D. . (2003). Proteomic identification of nitrated proteins in Alzheimer’s disease brain. Journal of Neurochemistry, 85(6), 1394-401. https://doi.org/10.1046/j.1471-4159.2003.01786.x
Lauderback, C. ., Drake, J. ., Zhou, D. ., Hackett, J. ., Castegna, A. ., Kanski, J. ., … Butterfield, D. . (2003). Derivatives of xanthic acid are novel antioxidants: application to synaptosomes. Free Radical Research, 37(4), 355-65. https://doi.org/10.1080/1071576021000040664
Butterfield, D. . (2002). Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer’s disease brain. A review. Free Radical Research, 36(12), 1307-13. https://doi.org/10.1080/1071576021000049890
Drake, J. ., Link, C. ., & Butterfield, D. . (1969). Oxidative stress precedes fibrillar deposition of Alzheimer’s disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiology of Aging, 24(3), 415-20. https://doi.org/10.1016/s0197-4580(02)00225-7 (Original work published 1969)
Turchan, J. ., Pocernich, C. ., Gairola, C. ., Chauhan, A. ., Schifitto, G. ., Butterfield, D. ., … Nath, A. . (2003). Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology, 60(2), 307-14. https://doi.org/10.1212/01.wnl.0000042048.85204.3d (Original work published 2003)
Butterfield, D. ., Castegna, A. ., Lauderback, C. ., & Drake, J. . (1969). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death. Neurobiology of Aging, 23(5), 655-64. https://doi.org/10.1016/s0197-4580(01)00340-2 (Original work published 1969)
Castegna, A. ., Aksenov, M. ., , Klein, J. ., Pierce, W. ., Booze, R. ., … Butterfield, D. . (2002). Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. Journal of Neurochemistry, 82(6), 1524-32. https://doi.org/10.1046/j.1471-4159.2002.01103.x
Butterfield, D. ., Griffin, S. ., Munch, G. ., & Pasinetti, G. . (2002). Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer’s disease brain exists. Journal of Alzheimer’s Disease : JAD, 4(3), 193-201. https://doi.org/10.3233/jad-2002-4309
Yatin, S. ., Varadarajan, S. ., & Butterfield, D. . (2000). Vitamin E Prevents Alzheimer’s Amyloid beta-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production. Journal of Alzheimer’s Disease : JAD, 2(2), 123-131. https://doi.org/10.3233/jad-2000-2212
Butterfield, D. ., Castegna, A. ., Drake, J. ., Scapagnini, G. ., & . (2002). Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutritional Neuroscience, 5(4), 229-39. https://doi.org/10.1080/10284150290028954